Literature DB >> 1593862

A high-affinity folate binding protein in proximal tubule cells of human kidney.

J Holm1, S I Hansen, M Høier-Madsen, L Bostad.   

Abstract

High-affinity 3H-folate binding in solubilized brush border membranes of human kidney cortex display characteristics such as apparent positive cooperativity typical of specific folate binding. The folate binding activity and the activity of the brush border membrane-marker enzyme, gamma-glutamyltransferase, were eightfold higher in brush border membranes compared to crude kidney homogenate. Ultrogel AcA 44 chromatography revealed a major (Mr approximately 100 kDa) and a minor (Mr approximately 25 kDa) folate binding protein in brush border membranes. The large molecular size form may represent a membrane-derived hydrophobic folate binding protein inserted in Triton X-100 micelles. This notion was supported by the identical molecular weights of the 100 kDa and 25 kDa folate binding peaks determined by sodium dodecylsulfate polyacrylamide gel electrophoresis and immunoblotting. The folate binding protein in renal brush border membranes cross reacted with rabbit antibodies against 25 kDa human milk folate binding protein, and showed immunoprecipitation in the presence of these antibodies. Paraffin embedded sections of kidney cortex showed immunostaining of cells in the convoluted proximal tubules after exposure to rabbit antiserum (1:8000 dilution). Glomeruli and distal tubules showed no immunostaining.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593862     DOI: 10.1038/ki.1992.7

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.

Authors:  Christian Brand; Valerie A Longo; Mike Groaning; Wolfgang A Weber; Thomas Reiner
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

2.  Folate binding protein: molecular characterization and transcript distribution in pig liver, kidney and jejunum.

Authors:  C M Van Hoozen; E H Ling; C H Halsted
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 3.  Folate-mediated chemotherapy and diagnostics: An updated review and outlook.

Authors:  Leyuan Xu; Qianming Bai; Xin Zhang; Hu Yang
Journal:  J Control Release       Date:  2017-02-22       Impact factor: 9.776

4.  Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy.

Authors:  Cristina Müller; Thomas L Mindt; Marion de Jong; Roger Schibli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-30       Impact factor: 9.236

5.  Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells.

Authors:  C P Leamon; P S Low
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

Review 6.  Preclinical Voxel-Based Dosimetry in Theranostics: a Review.

Authors:  Arun Gupta; Min Sun Lee; Joong Hyun Kim; Dong Soo Lee; Jae Sung Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-04-19

7.  Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors.

Authors:  Elnaz Nakhaei; Chan Woo Kim; Daiki Funamoto; Hikari Sato; Yuta Nakamura; Akihiro Kishimura; Takeshi Mori; Yoshiki Katayama
Journal:  Medchemcomm       Date:  2017-04-07       Impact factor: 3.597

8.  Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate.

Authors:  Stephanie Haller; Giovanni Pellegrini; Christiaan Vermeulen; Nicholas P van der Meulen; Ulli Köster; Peter Bernhardt; Roger Schibli; Cristina Müller
Journal:  EJNMMI Res       Date:  2016-02-09       Impact factor: 3.138

9.  Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization.

Authors:  Klaudia Siwowska; Raffaella M Schmid; Susan Cohrs; Roger Schibli; Cristina Müller
Journal:  Pharmaceuticals (Basel)       Date:  2017-08-15

Review 10.  Prospects in folate receptor-targeted radionuclide therapy.

Authors:  Cristina Müller; Roger Schibli
Journal:  Front Oncol       Date:  2013-09-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.